CAS: 105314-53-2; (S)-N-Methyl-3-(2-Methylphenoxy)-3-Phenyl-1-Propanamine

该化合物是具有高度药理特性的选择性的无肾上腺素再摄入抑制剂(NRI) . 作为对苯丙胺的活性对应剂,它展示了对无肾上腺素运输器(NET)的绑合性,有助于其在调制无生殖力...

结构式图片

上下游产品

2-methylchlorobenzene (R)-N-methyl-3-phenyl-3-hydroxypropylamine (R)-3-(2-methylphenoxy)-3-phenylprop-1-yl methanesulfonate methylamine atomoxetine hydr°Chloride S-rivastigmine-atomoxetine (R)-atomoxetine oxalate (-)-N-tert-butoxycarbonyl-N-methyl-3-phenyl-3-(2-methylphenoxy)propanamine

合成工艺路线路线简述

    📜苯基甘油醇置于三乙胺,三苯基膦,红铝,偶氮二甲酸二乙酯体系中,用 四氢呋喃,乙二醇二甲醚,乙醚,甲苯 用作溶剂,化学反应 13.0H,反应生成(3S)-N-甲基-3-(2-甲基苯氧基)-3-苯基丙烷-1-胺
    参考文献:Asymmetric Synthesis Of Both Enantiomers Of Tomoxetine And Fluoxetine. Selective Reduction Of 2,3-Epoxycinnamyl Alcohol With Red-Al
    标题:Asymmetric Synthesis Of Both Enantiomers Of Tomoxetine And Fluoxetine. Selective Reduction Of 2,3-Epoxycinnamyl Alcohol With Red-Al
    摘要:
    Doi:10.1021/jo00252A036

    专利信息


    专利号:US-8367868-B2
    优先权日:2006-10-16
    标题:Process for the synthesis of aryloxypropylamine and heteroaryloxypropylamine
    发明人:BERTOLINI GIORGIO; VERZOLA BARBARA; VERGANI DOMENICO
    权利人:ARCHIMICA SRL; BERTOLINI GIORGIO; VERZOLA BARBARA; VERGANI DOMENICO
    摘要:The present invention relates to a process for the synthesis of aryloxypropylamine and heteroaryloxypropylamine of formula I: n nwhere: A is aryl or heteroaryl, where the aryl is preferably a phenyl, optionally substituted, selected from benzyl and tolyl and the heteroaryl is preferably thiophenyl; Y is an aryl, preferably phenyl, a substituted phenyl or a naphthyl, where the substituted phenyl is preferably selected from tolyl, trihalomethyltolyl and alkoxytolyl, starting from a suitable amino alcohol of formula II:

    专利号:US-7507861-B2
    优先权日:2004-06-28
    标题:Process for the preparation of atomoxetine hydrochloride
    发明人:CASTELLI EUGENIO; LO MONACO GIUSEPPE; MANTOVANI SILVIA; DAVERIO PAOLA; RIVA PAOLO; VAILATI ALESSANDRA; BIANCHI STEFANO
    权利人:TEVA PHARM FINE CHEMICALS SRL
    摘要:The present invention provides improved processes for the preparation of atomoxetine hydrochloride under reaction conditions that improve reaction yields and facilitate commercial synthesis. In particular, the invention is directed to the synthesis of atomoxetine HCl by adding HCl to a mixture of (R)-(−)-tomoxetine (S)-(+)-mandelate with an organic solvent, with or without a base and water.

    专利号:US-7439399-B2
    优先权日:2004-06-28
    标题:Processes for the preparation of atomoxetine hydrochloride
    发明人:ARONHIME JUDITH; BIANCHI STEFANO; CASTELLI EUGENIO; DAVERIO PAOLA; MANTOVANI SILVIA; KOVACSNE-MEZEI ADRIENNE
    权利人:TEVA PHARM FINE CHEMICALS SRL
    摘要:The present invention provides improved processes for the preparation of atomoxetine hydrochloride under reaction conditions that improve reaction yields and facilitate commercial synthesis. In particular, the invention is directed to the synthesis of atomoxetine HCl by adding HCl to a mixture of (R)-(−)-tomoxetine (S)-(+)-mandelate with an organic solvent, with or without a base and water. In preferred embodiments, the atomoxetine hydrochloride produced is Form A.

    专利号:EP-1673335-A2
    优先权日:2004-06-28
    标 题 :Process for the preparation of atomoxetine hydrochloride
    发明人:CASTELLI EUGENIO; LO MONACO GIUSEPPE; MANTOVANI SILVIA; DAVERIO PAOLA; RIVA PAOLA; BIANCHI STEFANO
    权利人:TEVA PHARM FINE CHEMICALS SRL
    摘要:The present invention provides improved processes for the preparation of atomoxetine hydrochloride under reaction conditions that improve reaction yields and facilitate commercial synthesis. In particular, the invention is directed to the synthesis of atomoxetine HC1 by adding HCl to a mixture of (R)-(-)-tomoxetine (S)-(+)­mandelate with an organic solvent, with or without a base and water.

    专利号:US-2010105942-A1
    优先权日:2006-10-16
    标题:Process for the Synthesis of Aryloxypropylamine and Heteroaryloxypropylamine

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Chemoenzymatic Synthesis Of The Non-Tricyclic Antidepressants Fluoxetine, Tomoxetine And Nisoxetine
    作者:Hui-Ling Liu,Bård Helge Hoff,Thorleif Anthonsen
    摘要:3-Chloro-1-Phenylpropan-1-Ol And The Corresponding Butanoate, 3-Chloro-1-Phenyl-1-Propyl Butanoate, Were Kinetically Resolved Using Lipase B From Candida Antarctica Catalysis By Transesterification And Hydrolysis Respectively. The Resulting Chiral Building Blocks (S)- And (R)-3-Chloro-1-Phenylpropanol Were Converted Into Both Enantiomers Of The Antidepressant Drugs, Fluoxetine, Tomoxetine And Nisoxetine.

    合成参考文献


    摘要:S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知